Highlights and Quick Summary
- Other current liabilities for the quarter ending December 31, 2022 was $30.1 Million (a 71.76% increase compared to previous quarter)
- Year-over-year quarterly Other current liabilities increased by 56.9%
- Annual Other current liabilities for 2022 was $30.1 Million (a 134.6% increase from previous year)
- Annual Other current liabilities for 2021 was $12.9 Million (a -8.51% decrease from previous year)
- Annual Other current liabilities for 2020 was $14 Million (a -72.21% decrease from previous year)
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Other current liabilities of Precigen, Inc.
Most recent Other current liabilitiesof PGEN including historical data for past 10 years.Interactive Chart of Other current liabilities of Precigen, Inc.
Precigen, Inc. Other current liabilities for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2022 | $30.15 | $17.55 | $11.45 | $19.22 | $30.15 |
2021 | $12.85 | $23.03 | $0.1 | $0.17 | $12.85 |
2020 | $14.05 | $21.07 | $23.65 | $28.32 | $14.05 |
2019 | – | – | – | $50.54 | $50.54 |
2018 | – | – | – | $8.34 | $8.34 |
2017 | – | – | $6.97 | $6.89 | $70.42 |
2016 | $8.8 | $8.72 | $9.26 | $9.09 | $8.8 |
2015 | $6.93 | $16.21 | $7.56 | $7.31 | $6.93 |
2014 | $7.06 | $6.81 | – | – | $7.06 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology